Dr. Reddys Lab slips despite reporting sevenfold jump in Q1 consolidated net profit

30 Jul 2018 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 2072.55, down by 9.35 points or 0.45% from its previous closing of Rs. 2081.90 on the BSE.

The scrip opened at Rs. 2076.00 and has touched a high and low of Rs. 2090.00 and Rs. 2060.00 respectively. So far 53471 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2611.80 on 24-Jan-2018 and a 52 week low of Rs. 1888.00 on 21-May-2018.

Last one week high and low of the scrip stood at Rs. 2189.95 and Rs. 2033.00 respectively. The current market cap of the company is Rs. 34449.74 crore.

The promoters holding in the company stood at 26.79%, while Institutions and Non-Institutions held 44.27% and 14.60% respectively.

Dr. Reddys Laboratories has reported net profit at Rs 328.90 crore for the quarter ended June 30, 2018 as compared to a net loss of Rs 7.30 crore for the same quarter in the previous year. Total income of the company increased by 24.04% at Rs 2652.50 crore for Q1FY19 as compared Rs 2138.50 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported over 7-fold jump in its net profit at Rs 476.10 crore for the quarter under review as compared to Rs 66.60 crore for the same quarter in the previous year. Total consolidated income of the company increased by 12.33% at Rs 3786.90 crore for Q1FY19 as compared Rs 3371.20 crore for the corresponding quarter previous year.

Dr. Reddys Lab Share Price

5913.95 -2.85 (-0.05%)
13-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5913.95
Cipla 1421.00
Zydus Lifesciences 993.40
Lupin 1684.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.